PH12018500117A1 - Methods and compositions using bifidobacterium longum to optimize breastfeeding - Google Patents

Methods and compositions using bifidobacterium longum to optimize breastfeeding

Info

Publication number
PH12018500117A1
PH12018500117A1 PH12018500117A PH12018500117A PH12018500117A1 PH 12018500117 A1 PH12018500117 A1 PH 12018500117A1 PH 12018500117 A PH12018500117 A PH 12018500117A PH 12018500117 A PH12018500117 A PH 12018500117A PH 12018500117 A1 PH12018500117 A1 PH 12018500117A1
Authority
PH
Philippines
Prior art keywords
breastfeeding
optimize
compositions
methods
bifidobacterium longum
Prior art date
Application number
PH12018500117A
Inventor
Florence Rochat
Degonda Gabriela Bergonzelli
Jonas Hauser
Jeroen Antonius Johannes Schmitt
Nunes Tiago Alves
Valerie Marquardt
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PH12018500117A1 publication Critical patent/PH12018500117A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

B. longum ATCC BAA-999, or a composition comprising B. longum ATCC BAA-999, for use in an individual to; support breastfeeding initiation and/or to optimise breastfeeding duration and/or to optimize the quality and/or quantity ofbreast milk and/or to prevent or treat peripartum emotional distress and/or to regulate amygdala activity and/or to regulate the release of CRH, and to prevent or treat the negative effects of peripartum emotional distress in the offspring of individuals.
PH12018500117A 2015-08-31 2018-01-15 Methods and compositions using bifidobacterium longum to optimize breastfeeding PH12018500117A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562212148P 2015-08-31 2015-08-31
US201562220414P 2015-09-18 2015-09-18
US201562220408P 2015-09-18 2015-09-18
US201562236639P 2015-10-02 2015-10-02
US201562236638P 2015-10-02 2015-10-02
PCT/EP2016/070496 WO2017037105A1 (en) 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding

Publications (1)

Publication Number Publication Date
PH12018500117A1 true PH12018500117A1 (en) 2018-07-23

Family

ID=56852263

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018500117A PH12018500117A1 (en) 2015-08-31 2018-01-15 Methods and compositions using bifidobacterium longum to optimize breastfeeding

Country Status (7)

Country Link
EP (1) EP3344269A1 (en)
CN (1) CN107980002A (en)
BR (1) BR112018001179A2 (en)
CA (1) CA2994352A1 (en)
MX (1) MX2018002032A (en)
PH (1) PH12018500117A1 (en)
WO (1) WO2017037105A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201924696A (en) 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 Maternal supplement
CN111165828A (en) * 2020-03-24 2020-05-19 西安交通大学医学院第一附属医院 Composition and health food for promoting milk secretion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101095698B (en) * 2006-06-26 2010-12-01 青岛东海药业有限公司 Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
CA2742476A1 (en) * 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
ES2664828T3 (en) * 2009-08-25 2018-04-23 Nestec S.A. Bifidobacterium longum and functional GI disorders
EP2498789B1 (en) * 2009-11-11 2016-06-22 Alimentary Health Limited Probiotic bifidobacterium strain
WO2015090349A1 (en) * 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants

Also Published As

Publication number Publication date
CA2994352A1 (en) 2017-03-09
MX2018002032A (en) 2018-04-13
BR112018001179A2 (en) 2018-09-11
EP3344269A1 (en) 2018-07-11
WO2017037105A1 (en) 2017-03-09
CN107980002A (en) 2018-05-01

Similar Documents

Publication Publication Date Title
IL280743B (en) Methods for enriching or producing immune cell populations for adoptive therapy
MX2019009132A (en) Synergistic bacterial compositions and methods of production and use thereof.
HK1248548A1 (en) Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
MX2019005127A (en) Mesenchymal stem cells populations, their products, and use thereof.
PH12017500680A1 (en) Compositions and methods of use for treating metabolic disorders
MX2019014009A (en) Improved methods for manufacturing adoptive cell therapies.
PH12017500153A1 (en) Compositions and methods of use for treating metabolic disorders
MX2015006491A (en) Synergistic bacterial compositions and methods of production and use thereof.
MX2017014787A (en) Bacterial populations for promoting health.
WO2016090178A3 (en) Processes for producing exosomes in reduced oxygen culture conditions
MX2019007890A (en) 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells.
MA38860B1 (en) Immune-modulating progenitor cell (imp)
MX2017006263A (en) Hybrid dairy cattle and systems for maximizing hybrid advantage.
MX2017000775A (en) Meningococcus vaccines.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
SG11202107732XA (en) Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
PH12017500018A1 (en) Myo-inositol and probiotics, and their use
MX2014012164A (en) Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics.
PH12018500117A1 (en) Methods and compositions using bifidobacterium longum to optimize breastfeeding
MX2018005158A (en) Compounds for treatment of hypoproliferative disorders.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
HK1254739A1 (en) Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
SG10201805890QA (en) Compositions and methods for treatment of abnormal cell growth
NZ732071A (en) Low sugar sperm media and compositions
GB202007332D0 (en) Social distancing - concept seating